MedTrace Logo

Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma

NCT07220876 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 165

Last updated 2025-12-15

No results posted yet for this study

Summary

A Prospective, Multicenter, Single-Arm, Open-Label Clinical Trial

Conditions

  • Open Angle Glaucoma (OAG)

Interventions

DEVICE

VisiPlate Glaucoma Implant

Implant (micro-shunt) for glaucoma patients

Sponsors & Collaborators

  • Avisi Technologies Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-07
Primary Completion
2027-10-31
Completion
2027-10-31
FDA Device
Yes

Countries

  • United States
  • South Africa

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07220876 on ClinicalTrials.gov